Results 151 to 160 of about 18,063 (229)

Hydrolytically Stable Cationic Bis-MPA Dendrimers as Efficient Transfectants for Glioblastoma Cells and Primary Astrocytes. [PDF]

Biomacromolecules
Buendía A, Sanz Del Olmo N, Rodríguez-Clemente I, Wohlert J, Sztandera K, San Jacinto García J, Namata F, Malkoch M, Ceña V.   +8 more
europepmc   +1 more source

Self-Assembled Cysteamine Reporter Ligands for SERS Nitrate Detection in Continuous Flow. [PDF]

Langmuir
Küster T, Bothun GD.
europepmc   +1 more source

Neuroretinal structure changes in infantile nephropathic cystinosis. [PDF]

Orphanet J Rare Dis
Keidel LF, Jurkute N, Schworm B, Hohenfellner K, Priglinger S, Petzold A, Priglinger C.   +6 more
europepmc   +1 more source

Hypothesis: Taurine therapy of nephropathic cystinosis may correct the deficiencies of cysteamine therapy. [PDF]

Mol Genet Metab Rep
Thoene JG.
europepmc   +1 more source

Amino Compound-Synthesized Gold Nanoparticles for SARS-CoV-2 Antigen Delivery. [PDF]

Pharmaceutics
Rego LS, Favaro MTP, Rodrigues-Jesus MJ, Andreata-Santos R, Janini LMR, Seckler MM, Ferreira LCS, Azzoni AR.   +7 more
europepmc   +1 more source

The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis. [PDF]

Acta Derm Venereol
Wang S, Vaz R, Lysell J, Eisfeldt J, Sahlén P, Asad S, Wahlgren CF, Nordenskjöld M, Bradley M, Tapia-Paez I.   +9 more
europepmc   +1 more source

Early ADME and Preliminary Toxicity Studies of I-152, an <i>N</i>-Acetyl-l-Cysteine/<i>S</i>-Acetylcysteamine Conjugate. [PDF]

Chem Res Toxicol
Bartoccini F, Valeri A, Gregori M, Masini S, Bruschi M, Goracci L, Fraternale A, Piersanti G.   +7 more
europepmc   +1 more source

Biomarker potential of vanin-1-derived pantothenic acid in diabetes and its associated cardiovascular complications. [PDF]

Sci Rep
Shoura NK, Elbatreek MH, Mousa MM, El-Bassossy HM, El-Azzazy OY.   +4 more
europepmc   +1 more source

Blueshift of the silver plasmon band using controlled nanoparticle dissolution in aqueous solution [PDF]

, 2014
Kneipp, Katrin, Mogensen, Klaus Bo
core  

The Use of a Viscous Cysteamine Eyedrop in a Belgian Cohort: Early 3-Year Results. [PDF]

Ophthalmol Ther
Matthys E, Delbeke H, Van Keer K, Casteels I.   +3 more
europepmc   +1 more source